Encompass Health Corporation $EHC Shares Sold by VIRGINIA RETIREMENT SYSTEMS ET Al

Posted by Brian Himes on May 19th, 2026

VIRGINIA RETIREMENT SYSTEMS ET Al lessened its position in shares of Encompass Health Corporation (NYSE:EHC – Free Report) by 73.9% during the 4th quarter, Holdings Channel reports. The firm owned 4,731 shares of the company’s stock after selling 13,400 shares during the quarter. VIRGINIA RETIREMENT SYSTEMS ET Al’s holdings in Encompass Health were worth $502,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also recently bought and sold shares of EHC. Westside Investment Management Inc. grew its position in Encompass Health by 56.7% during the third quarter. Westside Investment Management Inc. now owns 279 shares of the company’s stock valued at $35,000 after buying an additional 101 shares during the period. Assetmark Inc. grew its position in shares of Encompass Health by 88.1% during the 3rd quarter. Assetmark Inc. now owns 299 shares of the company’s stock valued at $38,000 after acquiring an additional 140 shares during the period. Root Financial Partners LLC purchased a new position in shares of Encompass Health in the 3rd quarter valued at about $39,000. WPG Advisers LLC raised its holdings in Encompass Health by 73.3% in the 4th quarter. WPG Advisers LLC now owns 324 shares of the company’s stock worth $34,000 after purchasing an additional 137 shares during the period. Finally, Flagship Harbor Advisors LLC purchased a new position in Encompass Health during the fourth quarter worth approximately $37,000. 97.25% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, EVP Patrick William Tuer sold 682 shares of Encompass Health stock in a transaction on Monday, May 11th. The shares were sold at an average price of $104.56, for a total value of $71,309.92. Following the transaction, the executive vice president directly owned 24,755 shares of the company’s stock, valued at $2,588,382.80. The trade was a 2.68% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Treasurer Edmund Fay sold 11,937 shares of the stock in a transaction on Monday, March 9th. The stock was sold at an average price of $107.00, for a total transaction of $1,277,259.00. Following the sale, the treasurer owned 89,325 shares of the company’s stock, valued at approximately $9,557,775. This represents a 11.79% decrease in their position. The disclosure for this sale is available in the SEC filing. Company insiders own 1.80% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have recently commented on EHC shares. Wall Street Zen upgraded Encompass Health from a “hold” rating to a “buy” rating in a research report on Saturday, May 2nd. Barclays decreased their target price on Encompass Health from $153.00 to $140.00 and set an “overweight” rating on the stock in a research report on Tuesday, May 5th. Two equities research analysts have rated the stock with a Strong Buy rating, six have assigned a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average target price of $144.17.

Get Our Latest Research Report on Encompass Health

Encompass Health Trading Down 0.7%

Shares of Encompass Health stock opened at $105.89 on Tuesday. The company has a current ratio of 1.17, a quick ratio of 1.17 and a debt-to-equity ratio of 0.76. Encompass Health Corporation has a twelve month low of $92.77 and a twelve month high of $127.99. The firm has a market capitalization of $10.50 billion, a PE ratio of 17.68, a P/E/G ratio of 2.33 and a beta of 0.72. The firm’s 50-day moving average price is $102.91 and its 200 day moving average price is $106.11.

Encompass Health (NYSE:EHC – Get Free Report) last released its earnings results on Thursday, April 30th. The company reported $1.60 earnings per share for the quarter, beating the consensus estimate of $1.51 by $0.09. The business had revenue of $1.59 billion for the quarter, compared to the consensus estimate of $1.57 billion. Encompass Health had a return on equity of 18.28% and a net margin of 10.04%.The business’s quarterly revenue was up 9.0% compared to the same quarter last year. During the same quarter last year, the business posted $1.37 earnings per share. Encompass Health has set its FY 2026 guidance at 5.890-6.110 EPS. On average, sell-side analysts predict that Encompass Health Corporation will post 5.96 EPS for the current fiscal year.

Encompass Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st will be issued a $0.19 dividend. This represents a $0.76 annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend is Wednesday, July 1st. Encompass Health’s payout ratio is presently 12.69%.

Encompass Health Company Profile

(Free Report)

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.